Cited by 913D Printing in Biomedical ResearchTissue Engineering and Regenerative MedicineOsteoarthritis Treatment and Mechanisms

Biodegradable water-based polyurethane scaffolds with a sequential release function for cell-free cartilage tissue engineering

Wen, Yi-Ting, Dai, Niann-Tzyy, Hsu, Shan-hui·2019·Acta Biomaterialia

Abstract

Three-dimensional (3D) printing technology has rapidly developed as a promising technology for manufacturing tissue engineering scaffolds. Cells used in tissue engineering are subjected to the quality management and risk of contamination, while cell-free scaffolds may not have sufficient therapeutic efficacy. In this study, water-based 3D printing ink containing biodegradable polyurethane (PU), chemokine SDF-1, and Y27632 drug-embedding PU microspheres was printed at low temperature (-40 °C) to fabricate tissue engineering scaffolds with sequential drug release function. The scaffolds containing 200 ng/ml SDF-1 and 22 wt% Y27632-encapsulated microspheres (55 µg/ml Y27632 in microspheres) (abbreviated PU/SDF-1/MS_Y scaffolds) had the optimal performance. The structural design of the scaffolds allowed each of SDF-1 and Y27632 to be released sequentially in vitro and reach the effective concentration (∼100 ng/ml and 3.38 µg/ml, respectively) after the appropriate time (24 h and 62 h, respectively). Human mesenchymal stem cells (hMSCs) seeded in the scaffolds showed significant GAG deposition in 7 days. Besides, the gradual release of SDF-1 from the PU/SDF-1/MS_Y scaffolds could induce the migration of hMSCs. Implantation of the cell-free PU/SDF-1/MS_Y scaffolds in rabbit articular cartilage defects supported the potential of the scaffolds to promote cartilage regeneration. The 3D printed scaffolds with sequential releases of SDF-1 and Y27632 may have potential in cartilage tissue engineering. STATEMENT OF SIGNIFICANCE: The clinical success of tissue engineering depends highly on the quality of externally supplied cells, while cell-free scaffolds may not have sufficient therapeutic efficacy. In this manuscript, water-based 3D printing ink containing biodegradable polyurethane (PU), chemokine SDF-1, and Y27632 drug-embedding PU microspheres was printed at low temperature to fabricate tissue engineering scaffolds with sequential drug release function. The structural design of the scaffolds allowed each of SDF-1 and Y27632 to be released sequentially in vitro. SDF-1 was released earlier from the scaffolds to promote cell migration. The drug Y27632 was released later from the microspheres into the matrix of the scaffolds to induce the chondrogenic differentiation of the attracted cells. Implantation of the cell-free PU/SDF-1/MS_Y scaffolds in rabbit articular cartilage defects supported the potential of the scaffolds to promote cartilage regeneration. We hypothesized that the cell-free scaffolds may improve the clinical applicability and convenience without the use of exogenous cells or growth factor.

Integrity signals

Registry

Crossref · 10.1016/j.actbio.2019.02.044

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The LTD printing process is carried out at low temperatures, which preserves the bioactivity of temperature-sensitive bioactive agents such as growth factors and extracellular matrix proteins.

    “Unlike the FDM and SLS methods, the LTD printing process is carried out at low temperatures, which preserves the bioactivity of temperature-sensitive bioactive agents, such as growth factors and extracellular matrix proteins [109, 110].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wen, Y.-T., Dai, N.-T., & Hsu, S.-H.
Affiliations
  • National Taiwan University (TW)
  • National Defense Medical Center (TW)
Corresponding author
Hsu, Shan-hui
Venue
Acta Biomaterialia
Publisher
Elsevier BV
Published
2019-04
Volume
88
Pages
301-313
ISSN
1742-7061 (ISSN-L)
OpenAlex
W2918077371
Cited by
91
References
39
Citations by year
2026: 7 · 2025: 9 · 2024: 14 · 2023: 15 · 2022: 18 · 2021: 17 · 2020: 10 · 2019: 1
FWCI
4.05
Type
journal article
Language
en
Open access
closed
Locations
  • Acta Biomaterialia (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministry of Science and Technology, Taiwan (106-2221-E-002-079-MY2, 106-2622-E-002-007-CC1)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
Keywords
sequential drug release, Y-27632, human mesenchymal stem cells, cartilage regeneration, articular cartilage defects, low-temperature printing, cell migration
MeSH terms
Animals, Biocompatible Materials, Cartilage, Cell Movement, Humans, Male, Microspheres, Polyurethanes, Rabbits, Regeneration, Water, Chemokines, Chondrogenesis, Tissue Engineering, Cell Proliferation, Chemokine CXCL12, Tissue Scaffolds, Mesenchymal Stem Cells, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review